Editorial Pulmonology
Unraveling the Predictors of Treatment Outcomes and Compliance in Obstructive Sleep Apnea: A Comprehensive Retrospective Investigation in a Heterogeneous Cohort Hi Ade

Unraveling the Predictors of Treatment Outcomes and Compliance in Obstructive Sleep Apnea: A Comprehensive Retrospective Investigation in a Heterogeneous Cohort Hi Ade

Authors

Adel Hamad

Adel Hamad

University Hospital, Jordan

Corresponding

Published

October 20, 2026

Paper ID

PAP-000331

Status

Published

DOI

10.65712/tmj.4436197

Unraveling the Predictors of Treatment Outcomes and Compliance in Obstructive Sleep Apnea: A Comprehensive Retrospective Investigation in a Heterogeneous Cohort Hi Ade

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Editorial

Obstructive sleep apnea (OSA) is a highly prevalent sleep-related breathing disorder, typified by repetitive episodes of full or partial upper airway obstruction, engendering sleep fragmentation, intermittent hypoxia, and excessive daytime sleepiness (Young, Peppard, & Gottlieb, 2002). OSA prevalence rates in the adult population range between 9-38%, contingent upon age and gender demographics (Senaratna et al., 2017). Untreated OSA is implicated in numerous deleterious health outcomes, encompassing cardiovascular morbidity, hypertension, metabolic dysregulation, cognitive impairment, and diminished quality of life (Gottlieb et al., 2010; Marin, Carrizo, Vicente, & Agusti, 2005; Redline et al., 2010).

Therapeutic interventions for OSA conventionally necessitate the employment of continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BIPAP) apparatuses, designed to deliver uninterrupted airflow to preserve airway patency and ameliorate symptoms (Kryger, 2017). These modalities have demonstrated efficacy in enhancing both subjective and objective indices of sleep quality, daytime somnolence, and overall quality of life in OSA-afflicted individuals (Weaver & Grunstein, 2008). However, therapeutic success is predominantly contingent upon patient adherence to the prescribed regimen, with a considerable proportion of patients failing to attain optimal compliance (Sawyer et al., 2014).

Extant  Yallah yala  literature has underscored an array of factors potentially contributing to suboptimal adherence to CPAP and BIPAP therapy, encompassing device- or mask-related discomfort, adverse effects such as xerostomia and nasal congestion, and perceived absence of benefit (Bakker, Marshall, & Dement, 2001; Weaver & Sawyer, 2010). Moreover, patient demographic attributes, including age, gender, body mass index (BMI), and concomitant medical conditions, have been demonstrated to impact treatment adherence (Wozniak et al., 2014). Notwithstanding, the interplay between patient demographics, sleep study outcomes, and treatment compliance remains inadequately elucidated, particularly in heterogeneous patient cohorts.

In view of the substantial health ramifications of untreated OSA and the variable adherence to CPAP and BIPAP therapy, a more comprehensive comprehension of the determinants influencing treatment success is imperative. The present investigation endeavors to amass exhaustive data on patients subjected to polysomnography in our sleep laboratory, incorporating the presence of snoring and the success or failure of the sleep study. Subsequently, we shall scrutinize the demographics of those with unsuccessful sleep studies and discern potential etiologies. Furthermore, data procured from CPAP and BIPAP devices shall be evaluated, encompassing patient machine-generated data and parameters for assessing the apnea-hypopnea index (AHI) and other indices, to unveil the underlying causes of treatment failure or non-adherence.

This inquiry aspires to elucidate the reasons underpinning failed interventions, in addition to compliance challenges with the devices, and how these correlate with patient demographics. Our findings may facilitate an augmented understanding of the interplay between patients and devices, and how the overall therapeutic trajectory can be optimized based on local patient-derived data. This information can subsequently serve as a basis for formulating and validating hypotheses in future investigations, culminating in enhanced patient outcomes and a mitigation of the public health burden engendered by untreated sleep apnea.

References

  1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-1239.
  2. Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC, et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Med Rev. 2017;34:70-81.
  3. Gottlieb DJ, Yenokyan G, Newman AB, O'Connor GT, Punjabi NM, Quan SF, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The sleep heart health study. Circulation. 2010;122(4):352-360.
  4. Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet. 2005;365(9464):1046-1053.
  5. Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O'Connor GT, Resnick HE, et al. Obstructive sleep apnea-hypopnea and incident stroke: The sleep heart health study. Am J Respir Crit Care Med. 2010;182(2):269-277.
  6. Kryger M. Management of obstructive sleep apnea-hypopnea syndrome: Overview. In: Kryger M, Roth T, Dement WC, editors. Principles and Practice of Sleep Medicine. 6th ed. Elsevier; 2017. p. 1152-1156.
  7. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: The challenge to effective treatment. Proc Am Thorac Soc. 2008;5(2):173-178.
  8. Sawyer AM, Gooneratne NS, Marcus CL, Ofer D, Richards KC, Weaver TE. A systematic review of CPAP adherence across age groups: Clinical and empiric insights for developing CPAP adherence interventions. Sleep Med Rev. 2014;14(6):343-356.
  9. Bakker JP, Marshall NS, Dement WC. The new sleep: Wake disorders classification: What's in a name? Sleep Med Rev. 2001;5(5):361-366.
  10. Weaver TE, Sawyer AM. Adherence to continuous positive airway pressure treatment for obstructive sleep apnea: Implications for future interventions. Indian J Med Res. 2010;131:245-258.
  11. Wozniak DR, Lasserson TJ, Smith I. Educational, supportive and behavioral interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnea. Cochrane Database Syst Rev. 2014;2014(1):CD007736.